If you need an update on this week’s Pharma industry news, reports and select blog-post highlights, look no further. Here is a brief round-up: AMRI’s new CEO looking to buy competitors The Albany Business Review‘s Adam Sichko interviews AMRI’s President and CEO William S. Marth about his plans for AMRI, as well as his history […]

If you need an update on this week’s pharma news and select industry blog post highlights, look no further. Here is a brief round-up: NEWS/REPORTS HIGHLIGHTS Pharma Innovators Gather to Think “Beyond the Pill” An article written by the Windsor Star, explains that pharmaceutical companies need to look “beyond the pill” and find new ways […]

If you need an update on this week’s pharma news and select industry blog post highlights, look no further. Here is a brief round-up: NEWS HIGHLIGHTS Pharma CMOs Bouncing Back Specialty Chemicals magazine recaps CPhI Worldwide 2013 and its allied events, ICSE, P-Mec and Innopack, which were held in Frankfurt in October. According to the […]

If you need an update on this week’s pharma news and select industry blog post highlights, look no further. Here is a brief round-up: NEWS HIGHLIGHTS Level of Industry Response to FDA’s Quality Agreement Draft Guidance Reflects Contracting Challenges; Terminology at Issue The raft of industry comments FDA has received on its draft guidance on […]

This week the global biopharmaceutical company Alkermes was granted Fast Track status from the US FDA for ALKS 5461, the company’s once-daily treatment of major depressive disorder (MDD).  This follows news from the firm earlier in the week that plans to initiate Phase 3 trials for the candidate in early 2014. A recent release from […]